Skip to content

Early Phase Solutions

Cytel’s renowned clinical trial implementation team can help you devise optimal early phase trials which will help you explore the full potential of any new product.

We can provide experts in Data Management, Biostatistics, Statistical Programming, Medical Writing who can identify product value quickly and precisely, giving your clinical trial the best chance to prove its value.

Understanding the Potential of New Therapies

At Cytel, we are known for our proficiency in clinical trial biometrics solutions, and are experienced developers of statistical software and operational tools which can solve an array of early-phase clinical trial challenges. 

Our clinical trial implementation teams are trained to work with a variety of dose-escalation designs, and quickly pinpoint MTD using both rule-based and model-based dose-escalation. We implement with efficiency, and create the body of evidence you need to make vital decisions for your clinical trial.

Our high-efficiency clinical trial experts have worked across multiple therapeutic areas. When issues arise during an early-phase clinical trial, we have the industry experience to be responsive to challenges as they arise, as well as to spot novel opportunities for early-phase trials. 

Cytel’s early-phase teams have the advanced expertise to work with both Bayesian and Frequentist designs, initiate learning through small sample datasets, and make clinical data easily accessible to both a sponsor’s study team and trial clinicians.



Quickly identify the potential of new clinical therapies.



Use traditional and novel early-phase dose-escalation techniques that match your clinical operations needs.



Statistical insight delivered with speed and operating procedures designed for the curation of quality clinical data.

Contact Us

If you are looking for a clinical trial partner who will provide the best chance for success for your new product, we can help. Just get in touch with Cytel today.